Literature DB >> 30215132

[Neuroimmunology and rheumatology: overlap and differential diagnoses].

C Trebst1, T Kümpfel2.   

Abstract

Multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) are chronic inflammatory diseases of the central nervous system (CNS). They may cause inflammation in the brain, spinal cord and optic nerve. Both conditions must be differentiated from CNS manifestations of other systemic autoimmune diseases such as systemic lupus erythematosus (SLE), Sjögren's syndrome, autoinflammtory diseases and sarcoidosis, since amongst others myelitis and optic nerve inflammation may also occur in these conditions. Nevertheless, coexistence of MS or NMOSD with rheumatic disorders such as SLE or Sjögren's syndrome has also been reported especially in NMOSD. Since the therapeutic approach is different it is important to determine a clear diagnosis. In addition some drugs used in rheumatic disease such as anti-tumor necrosis factor biologics may induce inflammatory disease of the CNS and should be avoided in MS. An interdisciplinary approach between neuroimmunology and rheumatology is important for optimal care and treatment in such patients.

Entities:  

Keywords:  Autoinflammatory diseases; Lupus erythematosus, systemic; Multiple sclerosis; Neuromyelitis optica spectrum disorders; Neurosarcoidosis

Mesh:

Year:  2018        PMID: 30215132     DOI: 10.1007/s00115-018-0597-y

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  41 in total

1.  Association of rheumatoid arthritis with multiple sclerosis: report of 14 cases and discussion of its significance.

Authors:  Eric Toussirot; Edouard Pertuiset; Antoine Martin; Sylvie Melac-Ducamp; Michel Alcalay; Bruno Grardel; Paul Seror; Aleth Perdriger; Daniel Wendling; Denis Mulleman; Luc Beraneck; Xavier Mariette
Journal:  J Rheumatol       Date:  2006-03-15       Impact factor: 4.666

Review 2.  [Autoinflammatory syndromes : Practical approach to diagnostics and therapy].

Authors:  J B Kümmerle-Deschner
Journal:  Z Rheumatol       Date:  2016-08       Impact factor: 1.372

3.  The contemporary spectrum of multiple sclerosis misdiagnosis: A multicenter study.

Authors:  Andrew J Solomon; Dennis N Bourdette; Anne H Cross; Angela Applebee; Philip M Skidd; Diantha B Howard; Rebecca I Spain; Michelle H Cameron; Edward Kim; Michele K Mass; Vijayshree Yadav; Ruth H Whitham; Erin E Longbrake; Robert T Naismith; Gregory F Wu; Becky J Parks; Dean M Wingerchuk; Brian L Rabin; Michel Toledano; W Oliver Tobin; Orhun H Kantarci; Jonathan L Carter; B Mark Keegan; Brian G Weinshenker
Journal:  Neurology       Date:  2016-08-31       Impact factor: 9.910

4.  MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome.

Authors:  Sven Jarius; Klemens Ruprecht; Ingo Kleiter; Nadja Borisow; Nasrin Asgari; Kalliopi Pitarokoili; Florence Pache; Oliver Stich; Lena-Alexandra Beume; Martin W Hümmert; Marius Ringelstein; Corinna Trebst; Alexander Winkelmann; Alexander Schwarz; Mathias Buttmann; Hanna Zimmermann; Joseph Kuchling; Diego Franciotta; Marco Capobianco; Eberhard Siebert; Carsten Lukas; Mirjam Korporal-Kuhnke; Jürgen Haas; Kai Fechner; Alexander U Brandt; Kathrin Schanda; Orhan Aktas; Friedemann Paul; Markus Reindl; Brigitte Wildemann
Journal:  J Neuroinflammation       Date:  2016-09-27       Impact factor: 8.322

Review 5.  Immune-mediated adverse effects of biologicals used in the treatment of rheumatic diseases.

Authors:  Andrea T Borchers; Naama Leibushor; Gurtej S Cheema; Stanley M Naguwa; M Eric Gershwin
Journal:  J Autoimmun       Date:  2011-09-09       Impact factor: 7.094

6.  Familial Mediterranean fever-associated mutation pyrin E148Q as a potential risk factor for multiple sclerosis.

Authors:  T Kümpfel; L-A Gerdes; T Wacker; A Blaschek; J Havla; M Krumbholz; W Pöllmann; W Feneberg; R Hohlfeld; P Lohse
Journal:  Mult Scler       Date:  2012-02-15       Impact factor: 6.312

7.  Fluorodeoxyglucose positron emission tomography (FDG-PET) is useful in the diagnosis of neurosarcoidosis.

Authors:  Seza Bolat; Georg Berding; Reinhard Dengler; Martin Stangel; Corinna Trebst
Journal:  J Neurol Sci       Date:  2009-09-15       Impact factor: 3.181

8.  Inflammatory/demyelinating central nervous system involvement in familial Mediterranean fever (FMF): coincidence or association?

Authors:  G Akman-Demir; A Gul; E Gurol; H Ozdogan; S Bahar; A E Oge; H Gurvit; G Saruhan-Direskeneli; H Yazici; M Eraksoy
Journal:  J Neurol       Date:  2006-03-06       Impact factor: 4.849

9.  Leukoencephalopathy due to oral methotrexate.

Authors:  I González-Suárez; M J Aguilar-Amat; M Trigueros; A M Borobia; A Cruz; J Arpa
Journal:  Cerebellum       Date:  2014-02       Impact factor: 3.847

10.  International consensus diagnostic criteria for neuromyelitis optica spectrum disorders.

Authors:  Dean M Wingerchuk; Brenda Banwell; Jeffrey L Bennett; Philippe Cabre; William Carroll; Tanuja Chitnis; Jérôme de Seze; Kazuo Fujihara; Benjamin Greenberg; Anu Jacob; Sven Jarius; Marco Lana-Peixoto; Michael Levy; Jack H Simon; Silvia Tenembaum; Anthony L Traboulsee; Patrick Waters; Kay E Wellik; Brian G Weinshenker
Journal:  Neurology       Date:  2015-06-19       Impact factor: 9.910

View more
  1 in total

Review 1.  [From neuromyelitis optica to neuromyelitis optica spectrum disorder: from clinical syndrome to diagnistic classification].

Authors:  Orhan Aktas; Tania Kümpfel
Journal:  Nervenarzt       Date:  2021-03-16       Impact factor: 1.214

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.